Click here
Thursday 20 June 2013 Register   Login
Industry News
Wednesday 19 June
Novartis has announced results from a Phase III three-year follow-up study that showed Jakavi® (ruxolitinib) demonstrated improved overall survival and sustained reductions in spleen size compared to conventional therapy.
Monday 17 June
NANOBIOTIX (Euronext: NANO), a clinical-stage nanomedicine company pioneering novel approaches for the local treatment of cancer, has announced that its lead compound NBTXR3 has received authorisation from the French Medicine Agency, ANSM,(1) to start a clinical trial in patients with locally advanced cancers of the oral cavity or oropharynx (head and neck cancer), at the Institut Curie, Paris, France, a French leading cancer treatment centre. This represents a second indication for NBTXR3 which is also in clinical trials for soft tissue sarcoma.
Tuesday 4 June
The LUME-Lung 1 Phase III clinical trial results showed that the novel investigational compound nintedanib*, an oral triple angiokinase inhibitor, extended life by 2.3 months for non-small cell lung cancer (NSCLC) adenocarcinoma patients when added to docetaxel, versus placebo plus docetaxel.
Roundtable

 meeting

Safe preparation and administration of cytotoxics

Hospital Pharmacy Europe recently hosted a meeting of a panel of European expert pharmacists in Frankfurt, Germany to review the safe preparation and administration of cytotoxic drugs. Topics included hazards of cytotoxic drug preparation, safety assurance requirements and the likely impact of the European Resolution CM/ResAP(2011)1 on quality and safety assurance requirements for medicinal products prepared in pharmacies for the special needs of patients.

To download the article, click here


How to implement ‘smart’ pump technology successfully to help reduce IV medication errors

The purpose of this advisory board, recently held in Amsterdam, was to investigate the relatively slow uptake of ‘smart’ pumps in Europe and especially the use of drug libraries. Key points discussed included: administration of injections, use of ‘smart’ pumps, value for money, barriers to use and improved safety.

To download the article, click here

Supplements

HPE supplements are created to provide readers with dedicated resources and materials for specific areas of hospital pharmacy. Click on the images below to access the latest supplements:
CareFusion Handbook, BD Medical Handbook, Hospital Vascular Access Europe and Hospital Oncology & Haematology Europe
 
CareFusion+Handbk BD+Handbk
 
HVAE HOHE+3+FC

Advertisement Features

Web design, hosting and programming by ModeZero